selected publications
- Advanced Gastric Adenocarcinoma Presenting With Shoulder Pain and Diplopia. Cureus. 2025 Article GET IT
- Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival. Pathology, research and practice. 2025 Academic Article GET IT
- Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival. Research square. 2024 Article GET IT
-
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
World journal of gastrointestinal oncology.
2023
Academic Article
GET IT
Times cited: 22 -
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
Oncogene.
2023
Academic Article
GET IT
Times cited: 42 -
Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers.
Cancers.
2023
Information Resource
GET IT
Times cited: 5 -
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver international : official journal of the International Association for the Study of the Liver.
2023
Academic Article
GET IT
Times cited: 33 -
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2023
Information Resource
GET IT
Times cited: 179 -
Fatalistic cancer beliefs and self-reported cancer screening behaviors among diverse urban residents.
Journal of behavioral medicine.
2022
Academic Article
GET IT
Times cited: 6 -
A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma.
Current oncology (Toronto, Ont.).
2022
Information Resource
GET IT
Times cited: 17 -
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
Journal for immunotherapy of cancer.
2022
Academic Article
GET IT
Times cited: 56 -
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Hepatology communications.
2022
Academic Article
GET IT
Times cited: 19 -
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Cancers.
2021
Academic Article
GET IT
Times cited: 62 -
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
Liver cancer.
2021
Academic Article
GET IT
Times cited: 54 -
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
European journal of cancer (Oxford, England : 1990).
2021
Academic Article
GET IT
Times cited: 58 -
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.
American journal of clinical oncology.
2021
Academic Article
GET IT
Times cited: 34 -
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
Therapeutic advances in medical oncology.
2021
Academic Article
GET IT
Times cited: 23 -
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 32 -
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies.
Journal of clinical medicine.
2020
Information Resource
GET IT
Times cited: 19 -
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 50 -
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
Cancers.
2020
Academic Article
GET IT
Times cited: 69 -
Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
Expert opinion on biological therapy.
2019
Information Resource
GET IT
Times cited: 32 -
Optimizing Therapies in the Perioperative Management of Gastric Cancer.
Current treatment options in oncology.
2019
Information Resource
GET IT
Times cited: 14 - Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2019 Information Resource GET IT
-
Prognostic Utility of Tumor-Infiltrating Lymphocytes in Noncolorectal Gastrointestinal Malignancies.
International journal of surgical pathology.
2018
Academic Article
GET IT
Times cited: 2 -
T Lymphocytes and Autoimmunity.
International review of cell and molecular biology.
2018
Information Resource
GET IT
Times cited: 112 -
Role of "Second Look" Lymph Node Search in Harvesting Optimal Number of Lymph Nodes for Staging of Colorectal Carcinoma.
Gastroenterology research and practice.
2018
Academic Article
GET IT
Times cited: 12 - Acute myeloid leukemia with translocation (1;21). Molecular biology reports. 2018 Article GET IT
-
Autoimmune Hepatitis: A Risk Factor for Cholangiocarcinoma.
Case reports in gastroenterology.
2017
Article
GET IT
Times cited: 3 -
Benign Multicystic Peritoneal Mesothelioma: A Rare Condition in an Uncommon Gender.
Case reports in pathology.
2017
Article
GET IT
Times cited: 30 -
Plasmacytomas and Plasma-Cell Leukemia.
The New England journal of medicine.
2017
Article
GET IT
Times cited: 1 -
Fever, rash and agranulocytosis.
BMJ case reports.
2017
Article
GET IT
Times cited: 1 -
Immunotherapy-associated autoimmune hemolytic anemia.
Journal for immunotherapy of cancer.
2017
Article
GET IT
Times cited: 57 -
Nivolumab induced myxedema crisis.
Journal for immunotherapy of cancer.
2017
Article
GET IT
Times cited: 42 - Composite Lymphoma: Opposite Ends of Spectrum Meet. Journal of clinical medicine research. 2017 Article GET IT
-
Sweet syndrome: a painful reality.
BMJ case reports.
2016
Article
GET IT
Times cited: 12 -
RUSH for G6PD!.
Blood.
2016
Article
GET IT
Times cited: 4 - Circulating lymphoma cells of double-hit lymphoma. BMJ case reports. 2016 Article GET IT
- Sickle cell trait: not as benign as once thought. Journal of community hospital internal medicine perspectives. 2014 Article GET IT